[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361806-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361806-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inequity-of-nih-cancer-funding-in-the-united-states-an-ecological-study-predicting-funding-based-on-disease-burden-from-2008-through-2023-summary","Inequity of NIH cancer funding in the United States: an ecological study predicting funding based on disease burden from 2008 through 2023 - Summary","","National Institutes of Health (NIH) cancer funding was evaluated for allocation inequities by linking funding levels with disease burden and measuring how public interest may affect support. Using NIH funding data from 2008–2023, cancers were selected from the NIH Research Portfolio Online Reporting Tool and the 2021 Global Burden of Disease (GBD). Disability-adjusted life years (DALYs) and Google Trends informed a multivariable regression model, and residuals quantified percent over- or underfunding. Findings showed substantial cancer-specific disparity and highlighted the need to reassess funding decisions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inequity-of-nih-cancer-funding-in-the-united-states-an-ecological-study-predicting-funding-based-on-disease-burden-from-2008-through-2023-summary/361806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inequity-of-nih-cancer-funding-in-the-united-states-an-ecological-study-predicting-funding-based-on-disease-burden-from-2008-through-2023-summary/361806.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-17","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding NIH cancer funding?","Question",{"text":63,"@type":64},"To evaluate whether NIH funding allocation for cancers matches disease burden and to identify potential inequities, using an ecological model focused on cancer rather than unrelated diseases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were cancers selected for inclusion in the analysis?",{"text":68,"@type":64},"Cancers were included if they appeared in the NIH Research Portfolio Online Reporting Tool and were present in the 2021 Global Burden of Disease (GBD) study.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were used to predict appropriate NIH funding?",{"text":72,"@type":64},"The model used disease burden measured by DALYs and a public-interest proxy from Google Trends, and applied multivariable linear regression to determine expected funding.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361806,1790482052,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Articles   \nInequity of NIH cancer funding in the United States: an ecological study predicting funding based on disease burden from 2008 through 2023  \nEli Berglas,a David Musheyev,a Aaron B. Lavi,a Rachel S. Berglas,b Rachel Berglas,a and Abdo E. Kabarritia,∗  \naDepartment of Urology, State University of New York Downstate Health Sciences University, New York City, USA bAlbert Einstein College of Medicine, Bronx, NY, USA  \nSummary  \nBackground Disease burden has been used to predict National Institutes of Health (NIH) funding but included diseases with little underlying relationship. Here we focus on cancers to create a more appropriate model to allow for more targeted scrutinization of funding allocation.  \nMethods An ecological study using NIH funding data (2008–2023) was performed. Inclusion of cancers was based on their presence in the NIH Research Portfolio Online Reporting Tool and the 2021 Global Burden of Disease (GBD) study. Disability-adjusted life years (DALY) were collected and to evaluate the impact of public interest, Google Trends data was used. Multivariable linear regression determined appropriate funding based on disease burden and public interest. To quantify how each cancer’s funding differed from model predictions residual values were used to calculate the percent over/under funding.  \nFindings Fifteen cancers met inclusion criteria. Neuroblastoma had the greatest ratio of funding to DALYs per 100,000 people (US$14,000,000) while lung cancer had the lowest (US$300,000) . Stomach cancer was the most underfunded (197.9%[95% CI: 136.0%, 276.2%]) while brain cancer was the most overfunded (64.1%[95% CI: 53.8%, 72.1%]) . Even at their lowest funding values in the study period brain, breast, and colorectal cancer all had greater than 40% overfunding. Contrarily, the lowest annual funding for leukemia, uterine, and stomach cancer received less than 150% of expected funding. Despite its overfunding brain cancer had an increase in DALYs in the study period.  \nInterpretation Modeling by disease category demonstrated disparities in funding indicating the need for reevaluation for possible funding inequities. The year-by-year approach taken in this study will drive the ability for future research to better understand NIH funding decisions. Additionally, the role of public interest in research funding needs to be further evaluated to ensure that popularity does not override disease burden, in funding decisions.  \nFunding No Funding.  \nCopyright © 2025 The Author(s) . Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \nKeywords: Medical ethics; Equity; Health disparity; NIH; National institute of health; Research funding; Grant funding; Health economics; Health policy; Global health; Burdens of disease; DALY; Cancer  \nIntroduction  \nThe National Institutes of Health (NIH) is an important source of funding for researchers with roughly US$45 billion in grants being distributed in 2022 .1 It has set categories for funding using the Research, Condition, and Disease Categorization (RCDC) system to data mine for keywords of disease, conditions, and topics.2 For each keyword category, funding allocation is based on  \nthe requests and recommendations of the scientiﬁc community and NIH staff.3 It is inevitable that under the current framework, certain pathologies will not receive research funding representative of their disease burden. Within the RCDC reporting system, the NIH did not include disease burden metrics, such as disability-adjusted life year (DALY), years of healthy life lost due to disability (YLD), or years of life lost (YLL) .  \nThe Lancet Regional Health -Americas 2025;45: 101081  \nPublished Online xxx [https://doi.org/10](https://doi.org/10) . 1016/j.lana.2025 . 101081  \n*Corresponding author. South Brooklyn Health, SUNY Downstate Health Sciences University, Department","cbCaiomMHc2dn1ky","https://ap.wps.com/l/cbCaiomMHc2dn1ky","pdf",581389,"English","# Background\n# Methods\n# Findings\n# Interpretation\n# Evidence before this study\n# Added value of this study","[{\"question\":\"What is the study’s main goal regarding NIH cancer funding?\",\"answer\":\"To evaluate whether NIH funding allocation for cancers matches disease burden and to identify potential inequities, using an ecological model focused on cancer rather than unrelated diseases.\"},{\"question\":\"How were cancers selected for inclusion in the analysis?\",\"answer\":\"Cancers were included if they appeared in the NIH Research Portfolio Online Reporting Tool and were present in the 2021 Global Burden of Disease (GBD) study.\"},{\"question\":\"Which factors were used to predict appropriate NIH funding?\",\"answer\":\"The model used disease burden measured by DALYs and a public-interest proxy from Google Trends, and applied multivariable linear regression to determine expected funding.\"}]","Inequity of NIH cancer funding in the United States: an ecological study predicting funding based on disease burden from 2008 through 2023 - Summary | PDF",1790145636,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9c5cb98d983765062c32959a5f62fae.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/94a2155c833a0fe4b71e2c3e3dfa8d1f.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa364842181edd54c09b0b691a9dccf6.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cc329cd3222d5e1cebb1fdc7183b8ba.webp",980,1306]